Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Depreciation and Depletion (2016 - 2025)

Iradimed (IRMD) has disclosed Depreciation and Depletion for 13 consecutive years, with $269660.0 as the latest value for Q4 2025.

  • Quarterly Depreciation and Depletion rose 98.56% to $269660.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $795997.0 through Dec 2025, up 35.84% year-over-year, with the annual reading at $796000.0 for FY2025, 35.84% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $269660.0 at Iradimed, up from $256312.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $269660.0 in Q4 2025, with the low at $127139.0 in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $156594.6, with a median of $142043.0 recorded in 2022.
  • Peak annual rise in Depreciation and Depletion hit 98.56% in 2025, while the deepest fall reached 20.34% in 2025.
  • Over 5 years, Depreciation and Depletion stood at $135997.0 in 2021, then rose by 9.99% to $149581.0 in 2022, then rose by 9.67% to $164039.0 in 2023, then dropped by 17.21% to $135806.0 in 2024, then skyrocketed by 98.56% to $269660.0 in 2025.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $269660.0, $256312.0, and $135670.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.